X0508 4 2025-01-01 0001652130 Intellia Therapeutics, Inc. NTLA 0001810882 Lebwohl David C/O INTELLIA THERAPEUTICS, INC. 40 ERIE STREET; SUITE 130 CAMBRIDGE MA 02139 false true false false EVP, Chief Medical Officer false Common Stock 2025-01-01 4 M false 3189 A 97223 D Restricted Stock Unit 2025-01-01 4 M false 3189 0 D 2025-01-01 2031-03-02 Common Stock 3189 0 D Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. Includes 405 and 556 shares acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on June 30, 2024 and December 31, 2024, respectively. On March 3, 2021, the reporting person was granted 12,750 RSUs pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Company's common stock upon vesting, with 25% of the RSU vesting on January 1, 2022 and the remaining awards vesting as to 25% in substantially equal annual installments thereafter. James Basta, attorney-in-fact 2025-01-03